Explores how packaging influences cell viability and quality control data in cell therapy, suggesting its critical role in treatment success.
For cell therapies, packaging is not just a late-stage logistical consideration. From DMSO exposure time to QC container comparability, the choice of packaging system directly affects product quality, regulatory defensibility, and commercial scalability. View the infographic to learn how packaging systems can: Influence post-thaw cell viability and the reliability of QC data, Maintain a closed process throughout fill/finish and QC sampling, Enable manufacturability, scalability, and long-term commercial supply.
No takes yet. Share an insight, caveat, or question.
No authors listed (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: